mdma uses

MDMA, or Ecstasy, Shows Promise as a PTSD Treatment

Scientists test how pharmaceutical-grade MDMA combines with psychotherapy to help patients with a severe form of PTSD

The first time Lori Tipton tried MDMA, she was skeptical it would make a difference.

“I really was, at the beginning, very nervous,” Tipton said.

MDMA is the main ingredient in the club drug known as ecstasy or molly. But Tipton wasn’t taking pills sold on the street to get high. She was trying to treat her post-traumatic stress disorder by participating in a clinical trial.

After taking a dose of pure MDMA, Tipton lay in a quiet room with two specially trained psychotherapists. They sat next to her as she recalled some of her deepest traumas, such as discovering her mother’s body after Tipton’s mother killed two people and then herself in a murder-suicide.

“In the embrace of MDMA,” Tipton said, she could revisit that moment without the usual terror and panic. “I was able to find such empathy for myself.”

Scientists are testing how pharmaceutical-grade MDMA can be used in combination with psychotherapy to help patients with a severe form of PTSD that has not responded to other treatments. Unlike street drugs, which may be adulterated and unsafe, researchers use a pure, precisely dosed form of the drug.

MDMA is not yet available as a treatment for PTSD outside of clinical trials. But proponents are aiming for approval by the Food and Drug Administration, which granted breakthrough therapy status to MDMA-assisted psychotherapy in 2017.

Researchers are conducting Phase 3 clinical trials at more than a dozen sites. Clinicians who treat PTSD are hopeful the next round of trials will show that MDMA treatment is an effective option to relieve patient suffering.

“The problem is we haven’t had a new drug to treat PTSD in over 17 years,” said Dr. Sue Sisley, a physician and president of the Scottsdale Research Institute, based in Arizona. “There are certain illnesses that are just intractable and not responsive to traditional therapy, and we need to start thinking more broadly.”

But MDMA is a Schedule I controlled substance, which means it currently has no accepted medical use and has a “high potential for abuse” (something that MDMA’s therapeutic proponents dispute). Because of that designation, the current research trials are privately funded by the Multidisciplinary Association for Psychedelic Studies, or MAPS.


  1. December 10, 2020
    720p izle

    Thanks for fantastic info I was looking for this info for my mission. Malanie Kellen Chadabe

  2. December 31, 2020
    krystina bragg

    Thanks so much for the blog post.Thanks Again. Great.

  3. January 1, 2021
    maribeth bodden

    I get very useful information on your page, I feel lucky

  4. January 1, 2021
    andree syversen

    I will recommend your beautiful post site to my friends

  5. January 3, 2021
    edmond barash

    I am thinking of visiting your website again Thanks

  6. January 4, 2021
    leone bracken

    Very informative blog article.Much thanks again. Fantastic.

  7. January 6, 2021
    dorian bent

    Awesome article post.Much thanks again.

  8. January 9, 2021
    jaime grimaldi

    Greate article. Keep writing such kind of info on your blog.

  9. January 17, 2021
    gavin hibbetts

    I loved your blog.Really looking forward to read more. Will read on…

  10. January 21, 2021
    fake facebook

    I must say I read a great article with pleasure

  11. January 23, 2021

    Thanks again for the article. Really Cool.

  12. January 23, 2021


Leave a Comment

Your email address will not be published.

You cannot copy content of this page